Literature DB >> 26668261

Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness.

Tanya L Johnson1, Ursula Waack2, Sara Smith2, Harry Mobley2, Maria Sandkvist3.   

Abstract

UNLABELLED: Gram-negative bacteria express a number of sophisticated secretion systems to transport virulence factors across the cell envelope, including the type II secretion (T2S) system. Genes for the T2S components GspC through GspN and PilD are conserved among isolates of Acinetobacter baumannii, an increasingly common nosocomial pathogen that is developing multidrug resistance at an alarming rate. In contrast to most species, however, the T2S genes are dispersed throughout the genome rather than linked into one or two operons. Despite this unique genetic organization, we show here that the A. baumannii T2S system is functional. Deletion of gspD or gspE in A. baumannii ATCC 17978 results in loss of secretion of LipA, a lipase that breaks down long-chain fatty acids. Due to a lack of extracellular lipase, the gspD mutant, the gspE mutant, and a lipA deletion strain are incapable of growth on long-chain fatty acids as a sole source of carbon, while their growth characteristics are indistinguishable from those of the wild-type strain in nutrient-rich broth. Genetic inactivation of the T2S system and its substrate, LipA, also has a negative impact on in vivo fitness in a neutropenic murine model for bacteremia. Both the gspD and lipA mutants are outcompeted by the wild-type strain as judged by their reduced numbers in spleen and liver following intravenous coinoculation. Collectively, our findings suggest that the T2S system plays a hitherto-unrecognized role in in vivo survival of A. baumannii by transporting a lipase that may contribute to fatty acid metabolism. IMPORTANCE: Infections by multidrug-resistant Acinetobacter baumannii are a growing health concern worldwide, underscoring the need for a better understanding of the molecular mechanisms by which this pathogen causes disease. In this study, we demonstrated that A. baumannii expresses a functional type II secretion (T2S) system that is responsible for secretion of LipA, an extracellular lipase required for utilization of exogenously added lipids. The T2S system and the secreted lipase support in vivo colonization and thus contribute to the pathogenic potential of A. baumannii.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26668261      PMCID: PMC4751819          DOI: 10.1128/JB.00622-15

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  85 in total

1.  Multiple interactions between pullulanase secreton components involved in stabilization and cytoplasmic membrane association of PulE.

Authors:  O M Possot; G Vignon; N Bomchil; F Ebel; A P Pugsley
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

Review 2.  Type II secretion and pathogenesis.

Authors:  M Sandkvist
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 3.  Orlistat, a new lipase inhibitor for the management of obesity.

Authors:  A M Heck; J A Yanovski; K A Calis
Journal:  Pharmacotherapy       Date:  2000-03       Impact factor: 4.705

4.  Cloning and sequence analysis of the lipase and lipase chaperone-encoding genes from Acinetobacter calcoaceticus RAG-1, and redefinition of a proteobacterial lipase family and an analogous lipase chaperone family.

Authors:  E R Sullivan; J G Leahy; R R Colwell
Journal:  Gene       Date:  1999-04-16       Impact factor: 3.688

5.  Direct interaction of the EpsL and EpsM proteins of the general secretion apparatus in Vibrio cholerae.

Authors:  M Sandkvist; L P Hough; M M Bagdasarian; M Bagdasarian
Journal:  J Bacteriol       Date:  1999-05       Impact factor: 3.490

6.  Association of the cytoplasmic membrane protein XpsN with the outer membrane protein XpsD in the type II protein secretion apparatus of Xanthomonas campestris pv. campestris.

Authors:  H M Lee; K C Wang; Y L Liu; H Y Yew; L Y Chen; W M Leu; D C Chen; N T Hu
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

7.  Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

Authors:  J Garnacho-Montero; C Ortiz-Leyba; F J Jiménez-Jiménez; A E Barrero-Almodóvar; J L García-Garmendia; M Bernabeu-WittelI; S L Gallego-Lara; J Madrazo-Osuna
Journal:  Clin Infect Dis       Date:  2003-04-14       Impact factor: 9.079

8.  Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system.

Authors:  Andrew P Tomaras; Caleb W Dorsey; Richard E Edelmann; Luis A Actis
Journal:  Microbiology       Date:  2003-12       Impact factor: 2.777

9.  Novel virulence-associated type II secretion system unique to high-pathogenicity Yersinia enterocolitica.

Authors:  A Iwobi; J Heesemann; E Garcia; E Igwe; C Noelting; A Rakin
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli.

Authors:  Marija Tauschek; Rebecca J Gorrell; Richard A Strugnell; Roy M Robins-Browne
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

View more
  25 in total

1.  Serum Albumin and Ca2+ Are Natural Competence Inducers in the Human Pathogen Acinetobacter baumannii.

Authors:  German Matias Traglia; Brettni Quinn; Sareda T J Schramm; Alfonso Soler-Bistue; Maria Soledad Ramirez
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

Review 2.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 3.  Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond.

Authors:  Nicholas P Cianciotto; Richard C White
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

4.  Fluorogenic structure activity library pinpoints molecular variations in substrate specificity of structurally homologous esterases.

Authors:  Alex White; Andrew Koelper; Arielle Russell; Erik M Larsen; Charles Kim; Luke D Lavis; Geoffrey C Hoops; R Jeremy Johnson
Journal:  J Biol Chem       Date:  2018-07-13       Impact factor: 5.157

Review 5.  The Secrets of Acinetobacter Secretion.

Authors:  Brent S Weber; Rachel L Kinsella; Christian M Harding; Mario F Feldman
Journal:  Trends Microbiol       Date:  2017-02-16       Impact factor: 17.079

Review 6.  Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.

Authors:  Brent S Weber; Christian M Harding; Mario F Feldman
Journal:  J Bacteriol       Date:  2015-12-28       Impact factor: 3.490

7.  The structure of Acinetobacter-secreted protease CpaA complexed with its chaperone CpaB reveals a novel mode of a T2SS chaperone-substrate interaction.

Authors:  Darya V Urusova; Rachel L Kinsella; Nichole D Salinas; M Florencia Haurat; Mario F Feldman; Niraj H Tolia
Journal:  J Biol Chem       Date:  2019-07-18       Impact factor: 5.157

8.  Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems.

Authors:  Christian M Harding; Marina R Pulido; Gisela Di Venanzio; Rachel L Kinsella; Andrew I Webb; Nichollas E Scott; Jerónimo Pachón; Mario F Feldman
Journal:  J Biol Chem       Date:  2017-04-03       Impact factor: 5.157

Review 9.  Uncovering the mechanisms of Acinetobacter baumannii virulence.

Authors:  Christian M Harding; Seth W Hennon; Mario F Feldman
Journal:  Nat Rev Microbiol       Date:  2017-12-18       Impact factor: 60.633

10.  Defining the interaction of the protease CpaA with its type II secretion chaperone CpaB and its contribution to virulence in Acinetobacter species.

Authors:  Rachel L Kinsella; Juvenal Lopez; Lauren D Palmer; Nichole D Salinas; Eric P Skaar; Niraj H Tolia; Mario F Feldman
Journal:  J Biol Chem       Date:  2017-10-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.